[Alter BP. Inherited bone marrow failure syndromes. In: Handin RI, Stossel TP, Lux SE, Eds. Blood: Principles and Practice of Hematology. Philadelphia: JB Lippincott. 1995: 227-291.]Search in Google Scholar
[Bagby GC, Lipton JM, Sloand EM, Schiffer CA. Marrow failure. Hematology Am Soc Hematol Educ Program. 2004: 318-336.10.1182/asheducation-2004.1.31815561690]Search in Google Scholar
[Moldovan GL, D'Andrea AD. How the Fanconi anemia pathway guards the genome. Annu Rev Genet. 2009; 43: 223-249.10.1146/annurev-genet-102108-134222283071119686080]Search in Google Scholar
[Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007; 8(10): 735-748.10.1038/nrg215917768402]Search in Google Scholar
[Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet. 2010; 42(5): 406-409.10.1038/ng.57020400963]Search in Google Scholar
[Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, Joenje H, Schindler D, Rouse J, de Winter JP. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet. 2011; 43(2): 138-141.10.1038/ng.75121240277]Search in Google Scholar
[Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G., Gandini E. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi's anemia lymphocytes. Hum Genet. 1985; 69(1): 62-65.10.1007/BF002955303967890]Search in Google Scholar
[Joenje H, Eriksson AW, Frants RR, Arwert F, Houwen B. Erythrocyte superoxide dismutase deficiency in Fanconi's anemia. Nature. 1978; 290(8057): 142-143.]Search in Google Scholar
[Schindler D, Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet. 1988; 43(4): 429-435.]Search in Google Scholar
[Petrovic S, Leskovac A, Kotur-Stevuljevic J, Joksic I, Guc-Scekic M, Vujic D, Joksic G. Gender-related differences in the oxidant state of cells in Fanconi anemia heterozygotes. Biol Chem. 2011; 392(7): 625-632.10.1515/bc.2011.064]Search in Google Scholar
[Auerbach AD. A test for Fanconi's anemia. Blood. 1988; 72(1): 366-367.10.1182/blood.V72.1.366.366]Search in Google Scholar
[Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. In: Dracopoli NC, Ed. Short Protocols in Human Genetics: a Compendium of Methods From Current Protocols in Human Genetics. Hoboken: J. Wiley. 2004: 31-37.10.1002/0471142905.hg0807s3718428345]Search in Google Scholar
[Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross linking agents. Cancer Res. 1973; 33(8): 1829-1836.]Search in Google Scholar
[Wegner R-D, Stumm M. Diagnosis of chromosomal instability syndromes. In: Wegner R-D, Ed. Diagnostic Cytogenetics. Berlin: Springer-Verlag. 1999: 251-268.10.1007/978-3-642-59918-7_14]Search in Google Scholar
[An International System for Cytogenetic Nomenclature (ISCN 2009). In: Schaffer LG, Tommerup N, Eds. Basel: S. Karger, 2009.]Search in Google Scholar
[Auerbach AD, Rogatko A, Schroeder-Kurth TM, International Fanconi Anemia Registry. Relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989; 73(2): 391-396.10.1182/blood.V73.2.391.391]Search in Google Scholar
[Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996; 53(2): 99-110.10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.0.CO;2-Z]Search in Google Scholar
[Dokal I, Vulliamy T. Inherited bone marrow failure syndromes. Haematologica. 2010; 95(8): 1236-1240.10.3324/haematol.2010.025619]Search in Google Scholar
[Esmer C, Sanchez S, Ramos S, Molina B, Frias S, Carnavale A. DEB test for Fanconi anemia detection in patients with atypical phenotypes. Am J Med Genet. 2004; 124(1): 35-39.10.1002/ajmg.a.20327]Search in Google Scholar
[Liu JM, Buchwald M, Walsh CE, Young NS. Fanconi anemia and novel strategies for therapy. Blood. 1994; 12(84): 3995-4007.10.1182/blood.V84.12.3995.bloodjournal84123995]Search in Google Scholar
[Najean Y, Pecking A, Le Danvic M. Androgen therapy in aplastic anemia in childhood. A prospective study of 352 cases. Scand J Haematol. 1976; 22(4): 343-356.10.1111/j.1600-0609.1979.tb00430.x]Search in Google Scholar
[Kook H, Cho D, Cho SH, Hong WP, Kim CJ, Park JY, Yoon WS, Ryang DW, Hwang TJ. Fanconi anemia screening by diepoxybutane and mitomycin C tests in Korean children with bone marrow failure syndromes. J Korean Med Sci. 1998; 13(6): 623-628.10.3346/jkms.1998.13.6.623]Search in Google Scholar
[Cho SH, Kook H, Kim GM, Yoon WS, Cho TH, Hwang TJ. A clinical study of Fanconi's anemia. Korean J Pediatr Hematol Oncol. 1997; 4(1): 70-77.]Search in Google Scholar
[Ilgin H, Akarsu AN, Bokesoy FI. Cytogenetic and phenotypic findings in Turkish patients with Fanconi anemia. Tr J Med Sci. 1999; 29(2): 151-154.]Search in Google Scholar
[Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, Esperou H, Ferry C, Jubert C, Feugeas JP, Henri A, Toubert A, Socie G, Baruchel A, Sigaux F, D'Andrea AD, Gluckman E. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood. 2005; 105(3): 1329-1336.10.1182/blood-2004-05-1852]Search in Google Scholar
[Kwee ML, Poll EH, van de Kamp JJ, de Koning H, Eriksson AW, Joenje H. Unusual response to bifunctional alkylating agents in a case of Fanconi anaemia. Hum Genet. 1983; 64(4): 384-387.10.1007/BF00292372]Search in Google Scholar
[Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet. 1997; 5(3): 137-148.10.1159/000484749]Search in Google Scholar
[Gross M, Hanenberg H, Lobitz S, Friedl R, Herterich S, Dietrich R, Gruhn B, Schindler D, Hoehn H. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet Genome Res. 2002; 98(2-3): 126-135.10.1159/00006980512697994]Search in Google Scholar
[Youssoufian H. Natural gene therapy and the Darwinian legacy. Nat Genet. 1996; 13(3): 255-256.10.1038/ng0796-2558673116]Search in Google Scholar
[Castella M, Pujol R, Callén E, Ramírez MJ, Casado JA, Talavera M, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Estella J, Dasí Á, Rodríguez-Villa A, Gómez P, Tapia M, Molinés A, Figuera Á, Bueren JA, Surrallés J. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet. 2011; 48(4): 242-250.10.1136/jmg.2010.08421021217111]Search in Google Scholar